NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England
What the buyer wrote
NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England Offer reference number: CM/PHR/14/5446 Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months Additional information: The procurem…
Details
- What the buyer calls it
- NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 Aug 2017
- Work ends
- 31 Aug 2019
- Kind of work
- Recruitment and temporary staffing, Pharmacy and medicines
Who the buyer named
Martin Taylor was the named contact on this notice.